SASHA GRAHAM-GIVANS: Open Payments
NPI 1437832136 · BLOOMFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,304 in 21 payments from 8 companies in 2025. Trend: 2023 $116 · 2024 $544 · 2025 $1,304
Food & beverage: $1,081Education: $223
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $293 |
| Teva Pharmaceuticals USA, Inc. | 3 | $237 |
| ABBVIE INC. | 6 | $195 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| Alkermes, Inc. | 1 | $122 |
| E.R. Squibb & Sons, L.L.C. | 1 | $114 |
| Neurocrine BioSciences, Inc. | 4 | $96 |
Products named: CAPLYTA, VRAYLAR, FANAPT, Auvelity, VIVITROL, COBENFY, INGREZZA, AUSTEDO XR.
Industry payments across CT — which companies pay providers there.
